Back to Mariner, LLC Mariner, LLC

XLOXLO
7 quarters

Position history for Mariner, LLCMariner, LLC's holdings in XILIO THERAPEUTICS INC

No. Mariner exited its XLO (Xilio Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 25,000 shares worth $16,005. Mariner first reported XLO in Q3 2024 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$19,942

Total Shares Change

-25,317

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$8.41
0
2025-Q4
Unchanged
25,000
0.0%
$16,0050.0%$8.96
0
2025-Q3
Unchanged
25,000
0.0%
$21,0680.0%$11.80
0
2025-Q2
Unchanged
25,000
0.0%
$16,9980.0%$9.52
0
2025-Q1
Unchanged
25,000
0.0%
$18,1100.0%$10.14
0
2024-Q4
Decreased
25,000
-1.3%
$23,8750.0%$13.37
0
2024-Q3
New
25,317
-
$19,9420.0%$11.03
29

Other major holders of XLO: FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used